Healthcare professionals urged to report side effects of e-cigarettes
The Medicines and Healthcare products Regulatory Agency (MHRA) is calling on members of the public and healthcare professionals to report any suspected side effects or safety concerns with e-cigarettes and the e-liquids used for vaping.
The MHRA, which regulates medicines and medical devices in the UK, monitors the safety of healthcare products via the . It is urging members of the public and healthcare professionals to use this site to report any concerns.
It follows the introduction of on e-cigarette safety by the Tobacco Directive on 20 May 2017. Under the new rules, the size of an e-cigarette tank should not exceed 2ml and the maximum nicotine strength of liquids is set at 20mg/ml. At least 30% of the front and the back of packaging must contain a health warning saying: “This product contains nicotine which is a highly addictive substance.”
Although the rules contain no specific restrictions on flavours or standard formulations, the MHRA has its own on ingredients that should not be included in e-cigarettes or e-liquids.
Deborah Arnott, chief executive of Action on Smoking and Health, says: “There are currently 2.9 million e-cigarette users in Great Britain, over half of whom have quit smoking. E-cigarettes are playing an important role in supporting smokers to switch from tobacco smoking. The new regulations which require notification to the MHRA about the products should give people further confidence in the e-cigarette market. As the market continues to develop we hope to see products go through the more stringent licensing process and become licensed as medicines and available on prescription.”
Citation: The Salvadore DOI: 10.1211/PJ.2017.20203085
Recommended from Pharmaceutical Press
Commonly known as the Orange Guide, this book is an essential reference for all involved in the manufacture or distribution of medicines in Europe.£82.00
Guidance for students or researchers undertaking a multi-centre research project in health services, medicines use and professional practice.£38.00
Essential guidance for distributors of medicines for human use in Europe, compiled by the MHRA.£72.00
An essential guide on pharmacovigilance of medicinal products for human use. Practical advice for developing effective pharmacovigilance systems.£38.00
The 2016 pocket guide to drug interactions and their management, for the busy healthcare professional.£31.00